Published on
May 11, 2026
- 12:00 GMT
Diamond Therapeutics Receives Multi-Million Dollar US Government Funding for Phase 2 Clinical Trial of Anxiety Treatment
ARPA-H funding will enable study’s expansion to US as part of Agency’s program to drive development of new, effective therapies for behavioral health BIRMINGHAM, AL, UNITED STATES, May 11, 2026 /EINPresswire.com/ -- Diamond Therapeutics Inc., a clinical …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
